These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9305607

  • 1. Effect of the multidrug inhibitor GG918 on drug sensitivity of human leukemic cells.
    Zhou DC, Simonin G, Faussat AM, Zittoun R, Marie JP.
    Leukemia; 1997 Sep; 11(9):1516-22. PubMed ID: 9305607
    [Abstract] [Full Text] [Related]

  • 2. Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918.
    Wallstab A, Koester M, Böhme M, Keppler D.
    Br J Cancer; 1999 Mar; 79(7-8):1053-60. PubMed ID: 10098736
    [Abstract] [Full Text] [Related]

  • 3. The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia.
    den Boer ML, Pieters R, Kazemier KM, Janka-Schaub GE, Henze G, Veerman AJ.
    Leukemia; 1998 Jun; 12(6):912-20. PubMed ID: 9639420
    [Abstract] [Full Text] [Related]

  • 4. Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cells.
    Chiodini B, Bassan R, Barbui T.
    Leuk Lymphoma; 1999 May; 33(5-6):485-97. PubMed ID: 10342576
    [Abstract] [Full Text] [Related]

  • 5. Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918.
    Witherspoon SM, Emerson DL, Kerr BM, Lloyd TL, Dalton WS, Wissel PS.
    Clin Cancer Res; 1996 Jan; 2(1):7-12. PubMed ID: 9816083
    [Abstract] [Full Text] [Related]

  • 6. A new PCR MIMIC strategy to quantify low mdr1 mRNA levels in drug resistant cell lines and AML blast samples.
    Illmer T, Schaich M, Oelschlägel U, Nowak R, Renner U, Ziegs B, Subat S, Neubauer A, Ehninger G.
    Leuk Res; 1999 Jul; 23(7):653-63. PubMed ID: 10400187
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression.
    Marie JP, Faussat-Suberville AM, Zhou D, Zittoun R.
    Leukemia; 1993 Jun; 7(6):825-31. PubMed ID: 8099135
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines.
    Bailly JD, Muller C, Jaffrézou JP, Demur C, Gassar G, Bordier C, Laurent G.
    Leukemia; 1995 May; 9(5):799-807. PubMed ID: 7769842
    [Abstract] [Full Text] [Related]

  • 13. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U, Lage H, Jordan A, Walther W, Bates SE, Litman T, Hohenberger P, Dietel M.
    Int J Cancer; 2002 Feb 20; 97(6):751-60. PubMed ID: 11857350
    [Abstract] [Full Text] [Related]

  • 14. Idarubicin overcomes P-glycoprotein-related multidrug resistance: comparison with doxorubicin and daunorubicin in human multiple myeloma cell lines.
    Roovers DJ, van Vliet M, Bloem AC, Lokhorst HM.
    Leuk Res; 1999 Jun 20; 23(6):539-48. PubMed ID: 10374847
    [Abstract] [Full Text] [Related]

  • 15. HZ08 reverse P-glycoprotein mediated multidrug resistance in vitro and in vivo.
    Hu Z, Zhou Z, Hu Y, Wu J, Li Y, Huang W.
    PLoS One; 2015 Jun 20; 10(2):e0116886. PubMed ID: 25689592
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL, Bendayan R, Rauth AM, Wu XY.
    J Control Release; 2006 Dec 01; 116(3):275-84. PubMed ID: 17097178
    [Abstract] [Full Text] [Related]

  • 17. Prolongation of medium exchange is associated with a decrease in function but not expression of the P-glycoprotein pump in leukaemic cells.
    Hegewisch-Becker S, Faltz C, Hossfeld DK.
    Eur J Haematol; 1996 Dec 01; 56(1-2):12-22. PubMed ID: 8599988
    [Abstract] [Full Text] [Related]

  • 18. In vitro effect of GF120918, a novel reversal agent of multidrug resistance, on acute leukemia and multiple myeloma cells.
    den Ouden D, van den Heuvel M, Schoester M, van Rens G, Sonneveld P.
    Leukemia; 1996 Dec 01; 10(12):1930-6. PubMed ID: 8946933
    [Abstract] [Full Text] [Related]

  • 19. Multidrug resistance (Mdr1) gene expression in peripheral blasts from patients with acute leukemia only rarely increases during disease progression after combination chemotherapy.
    Gruber A, Areström I, Albertioni F, Björkholm M, Peterson C, Vitols S.
    Leuk Lymphoma; 1995 Aug 01; 18(5-6):435-42. PubMed ID: 8528050
    [Abstract] [Full Text] [Related]

  • 20. Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells.
    Berman E, McBride M.
    Blood; 1992 Jun 15; 79(12):3267-73. PubMed ID: 1596567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.